Shimadzu Instrumentation Corporation announces a collaboration with VpH, to establish the Medical Botanical Center of Excellence. The Center represents the first fully comprehensive pharmaceutical grade Medical Botanical Testing Platform in Texas.
The center will be positioned to support the State of Texas Compassionate Use Act (CUP) and Compassionate Use Registry of Texas (CURT), an initiative to help provide the requisite quality assurance necessary to support the prescribing of a key component of medical botanical for patients with intractable epilepsy. Vyripharm maintains research partnerships with Institutions throughout the Texas Medical Center focused on the integration and effects of medical botanicals with traditional standard of care treatments for cancer, post-traumatic stress disorder, substance abuse, contact sport injuries and neurological disorders.
The Center will be positioned to provide the State of Texas the flexibility and protection of a Core Center of Reference to facilitate potential expansion of the CUP.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation.
VpH is a subsidiary of privately held Vyripharm located in the Texas Medical Center in Houston, Texas. Vyripharm holds a botanical testing patent and patent rights to technology platforms currently being studied in conjunction with medical botanicals. Shimadzu and VpH are dedicated to establishing the most powerful medical botanical testing platform in the industry.